(Approval lapsed) GAMUNEX normal immunoglobulin (Human) 5g/50ml and 10g/100ml intravenous solution vial (USA)
Section 19A approved medicine
(Approval lapsed) GAMUNEX normal immunoglobulin (Human) 5g/50ml and 10g/100ml intravenous solution vial (USA)
Section 19A approval holder
Grifols Australia Pty Ltd ABN 35 050 104 875
Phone
03 9535 9336
Approved until
Status
Expired
Medicines in short supply/unavailable
GAMUNEX normal immunoglobulin (Human) 5g/50ml and 10g/100ml intravenous solution vial - ARTG 117238
Indication(s)
Replacement therapy in:
- Primary Immunodeficiency (PI) Diseases.
- Symptomatic Hypogammaglobulinaemia secondary to underlying disease or treatment.
Immunomodulation in:
- Idiopathic Thrombocytopaenic Purpura (ITP), in patients at high risk of bleeding or prior to surgery to correct the platelet count.
- Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).
Images
